Axe Compute

Axe Compute CapEx/D&A

The CapEx to Depreciation Ratio of Axe Compute (AGPU) as of Nov 3, 2026 is 0.06. In the previous year, CapEx to Depreciation Ratio was 0.09 — a change of -33.30% (lower).

CapEx/D&A

0.06

YoY

-33.30%

Last updated:

CapEx to Depreciation Ratio of Axe Compute is 2024 0.06 . CapEx to Depreciation Ratio of Axe Compute was 2023 0.09 . It decreases by -33.30% lower compared to the previous year.

The Axe Compute CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2023
0.09 USD
Jan 1, 2024
0.06 USD
The Axe Compute CapEx/D&A history
YEARCapEx/D&AYoY
0.06-33.30%
0.09—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axe Compute Stock analysis

What does Axe Compute do? Predictive Oncology, Inc. generates revenue through its subsidiaries Helomics Holding Corporation and Skyline Medical Inc. Helomics applies artificial intelligence to patient tumor data to personalize cancer therapies and develop new-targeted therapies, offering CLIA-certified clinical testing for oncologists. Skyline Medical Inc. markets the STREAMWAY System, which automates medical fluid disposal, targeting hospitals and clinics globally. The company's products serve healthcare providers seeking advanced diagnostic and waste management solutions. Helomics focuses on personalized cancer treatment decisions using AI-driven analysis, while Skyline Medical Inc. provides automated fluid disposal systems. The STREAMWAY System is sold through domestic and international divisions to medical facilities requiring efficient waste handling. TumorGenesis Inc. supports laboratory-based tumor research, complementing Helomics' clinical offerings. The company's revenue streams include AI-based therapy personalization services and the STREAMWAY System sales. Healthcare providers, including oncologists and medical facilities, purchase these products to enhance treatment precision and operational efficiency. Subsidiaries operate under the parent company's structure, with Helomics handling AI applications and Skyline Medical managing medical device distribution. Axe Compute is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axe Compute stock

CapEx to Depreciation Ratio of Axe Compute is 0.06 in 2024.

CapEx to Depreciation Ratio of Axe Compute changed from 0.09 to 0.06, representing a -33.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Axe Compute since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Axe Compute with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Axe Compute

All Key Metrics — Axe Compute